Pediatric Thrombocytopenia is a condition in which you have a low blood platelet count. Platelets (thrombocytes) are colorless blood cells that help blood clot. Platelets stop bleeding by clumping and forming plugs in blood vessel injuries. Thrombocytopenia often occurs as a result of a separate disorder, such as leukemia or an immune system problem. Or it can be a side effect of taking certain medications. It affects both children and adults. Thrombocytopenia may be mild and cause few signs or symptoms. In rare cases, the number of platelets may be so low that dangerous internal bleeding occurs. Treatment options are available.
An increasing body of evidence has been gathered since the mid-1960s to support a link between vaccinations, particularly the measles-mumps-rubella (MMR) vaccine and thrombocytopenic purpura. The incidence rate is estimated to be between one in 25,000 to one in 40,000 doses of MMR this is much less frequent than after natural infection with measles (common), rubella (one in 3000 cases) and varicella. The purpose of the present commentary is to review vaccine-associated thrombocytopenia (VATP).
Specific treatments for thrombocytopenia will be determined by your child’s physicians based on the cause and severity of the disease, as well as your child’s tolerance for medications, procedures and therapies. Mild cases may not require treatment and may resolve on their own. Blood transfusions with platelets or red blood cells are sometimes needed.
Pediatric thrombocytopenia Routine blood counts are recommended in particular for male infants with low birth weight born to mothers with moderate to severe thrombocytopenia.